Testimonies from the Trenches Series - Buprenorphine in Residential Treatment Settings (On-Demand)-Testimonies from the Trenches - Buprenorphine in Residential Treatment Settings

Testimonies from the Trenches - Buprenorphine in Residential Treatment Settings

Video Transcription

Video Summary

In this video, Dr. Michael A. McCormick, the medical director of the Healthcare Professionals Program at the Karen Foundation, discusses the introduction of medications for opioid use disorder to patients in residential treatment settings. He talks about the different medications available, such as buprenorphine, naltrexone, and methadone, and discusses their usage and dosing. He emphasizes the need for a personalized approach when determining the appropriate medication for each patient, considering factors such as their history of use, physical exam, personal experience, and risk of precipitated withdrawal. Dr. McCormick also discusses the importance of post-discharge referrals and the ongoing support needed for long-term recovery. He addresses common concerns and challenges, such as public perception, family involvement, and the role of 12-step programs. Overall, Dr. McCormick provides insight into the complexities of medication-assisted treatment for opioid use disorder and the considerations that healthcare professionals need to take into account when implementing these treatments. This summary is based on the transcript of the video and no additional external sources were used.

Keywords

medications for opioid use disorder

buprenorphine

naltrexone

methadone

personalized approach

post-discharge referrals

medication-assisted treatment